Marshall Wace, LLP Pfizer Inc Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Pfizer Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 14,730,207 shares of PFE stock, worth $367 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
14,730,207
Previous 5,378,173
173.89%
Holding current value
$367 Million
Previous $150 Million
183.29%
% of portfolio
0.55%
Previous 0.21%
Shares
26 transactions
Others Institutions Holding PFE
# of Institutions
3,256Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$12.9 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.24 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.08 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.25 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $140B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...